U.S. Markets closed
  • S&P Futures

    4,034.25
    -1.50 (-0.04%)
     
  • Dow Futures

    32,747.00
    -27.00 (-0.08%)
     
  • Nasdaq Futures

    12,868.75
    +1.50 (+0.01%)
     
  • Russell 2000 Futures

    1,793.20
    -0.10 (-0.01%)
     
  • Crude Oil

    69.50
    +0.17 (+0.25%)
     
  • Gold

    1,948.20
    +7.10 (+0.37%)
     
  • Silver

    22.56
    +0.13 (+0.58%)
     
  • EUR/USD

    1.0771
    -0.0001 (-0.0108%)
     
  • 10-Yr Bond

    3.6060
    +0.1250 (+3.59%)
     
  • Vix

    21.38
    -2.77 (-11.47%)
     
  • GBP/USD

    1.2212
    -0.0007 (-0.0598%)
     
  • USD/JPY

    132.5200
    +0.0600 (+0.0453%)
     
  • BTC-USD

    28,100.05
    +213.57 (+0.77%)
     
  • CMC Crypto 200

    613.13
    +8.09 (+1.34%)
     
  • FTSE 100

    7,536.22
    +132.37 (+1.79%)
     
  • Nikkei 225

    27,319.79
    +374.12 (+1.39%)
     

UiPath Reports Third Quarter Fiscal 2023 Financial Results

ARR grew 36 percent year-over-year reaching $1.110 billion driven by net new ARR of $67 million

NEW YORK, December 01, 2022--(BUSINESS WIRE)--UiPath, Inc. (NYSE: PATH), a leading enterprise automation software company, today announced financial results for its third quarter fiscal 2023 ended October 31, 2022.

"We are pleased with our third quarter fiscal 2023 results as ARR grew 36 percent year-over-year and we delivered meaningful non-GAAP operating margin expansion," said Rob Enslin, UiPath Co-Chief Executive Officer. "Our new go-to-market initiatives are driving results and resonating with customers. We closed several notable third quarter deals using this value-selling approach and are widely engaged with both new and existing customers as we head into the last quarter of fiscal year 2023."

"UiPath continues to be differentiated by our platform approach, which is at the core of our success," said Daniel Dines, UiPath Co-Founder and Co-Chief Executive Officer. "Our latest release, 2022.10, further expands our competitive advantage with market-leading capabilities at every stage in the automation lifecycle, from discover to automate to operate. This cohesive approach makes it easier and faster for organizations to efficiently scale their automation programs and drive meaningful business outcomes."

Third Quarter Fiscal 2023 Financial Highlights

  • Revenue of $262.7 million increased 19 percent year-over-year.

  • ARR of $1.110 billion increased 36 percent year-over-year.

  • Net new ARR of $66.8 million.

  • Dollar based net retention rate of 126 percent.

  • GAAP gross margin was 84 percent.

  • Non-GAAP gross margin was 86 percent.

  • GAAP operating loss was $(67.0) million.

  • Non-GAAP operating income was $18.0 million.

  • Net cash used in operations was $27.3 million.

  • Non-GAAP adjusted free cash flow was negative $24.1 million.

  • Cash, cash equivalents, and marketable securities were $1.7 billion as of October 31, 2022.

"Non-GAAP operating income of $18 million for the quarter was the result of disciplined capital deployment and cost management. Our durable financial model and strong balance sheet give us the resources to continue to invest in long-term growth and drive a path to sustained profitability, both of which are core to our go-forward strategy," said Ashim Gupta, UiPath Chief Financial Officer.

Financial Outlook

For the fourth quarter fiscal 2023, UiPath expects:

  • Revenue in the range of $277 million to $279 million.

  • ARR in the range of $1,174 million to $1,176 million as of January 31, 2023.

  • Non-GAAP operating income of approximately $35 million.

Reconciliation of non-GAAP operating income guidance to the most directly comparable GAAP measure is not available without unreasonable efforts on a forward-looking basis due to the high variability, complexity and low visibility with respect to the charges excluded from this non-GAAP measure, including, in particular, the effects of stock-based compensation expense specific to equity awards that are directly impacted by fluctuations in our stock price. We expect the variability of the above charges to have a significant, and potentially unpredictable, impact on our future GAAP financial results.

Recent Business Highlights

  • Launched its latest platform updates to support app development, expand automation use cases: Announced at the UiPath FORWARD 5 global conference, the 22.10 release offers even more enhancements that allow businesses to automate more, automate faster and with less friction, expand user and builder bases, and operate it all more efficiently and effectively.

  • Announced technology partnerships with:

    • Microsoft to build best-in-class automation experiences and integrations between the two strategic partners. Microsoft Azure is a preferred cloud platform for UiPath, including the UiPath Automation Cloud™, while UiPath is a preferred enterprise automation partner at Microsoft.

    • OutSystems, a global leader in high-performance application development, to combine the power of the UiPath Business Automation Platform with OutSystems high-performance low-code.

  • Announced additional strategic collaborations with:

    • ManpowerGroup® (NYSE: MAN), a leading global workforce solutions company and long-term partner of UiPath, to expand and accelerate go-to-market workforce solutions in automation.

    • CGI (TSX: GIB.A) (NYSE: GIB), one of the largest independent IT and business consulting services firms in the world, to expand automation deployments among CGI clients via managed services.

    • qBotica to introduce Automation Cube, qBotica’s go-to-market UiPath managed services practice that offers customers advantages such as turnkey automation tailored to their industry and operations.

  • Announced FHIR-enabled API automation to simplify integration and transform patient experiences in healthcare: Organizations can now use UiPath Integration Service with Fast Healthcare Interoperability Resource (FHIR)-enabled endpoints to orchestrate turnkey automations within Electronic Health Record systems meeting the Office of the National Coordinator for Health Information Technology Cures Act FHIR certification criteria – such as Epic and Oracle Cerner – and a broader set of health IT systems that have voluntarily deployed FHIR endpoints.

  • Received widespread industry recognition, including:

    • Honored as an RPA Leader for the sixth consecutive year and Star Performer in the Technology Provider Landscape, according to Everest Group’s Robotic Process Automation Products PEAK Matrix® Assessment 2022. This assessment analyzes the changing dynamics of the RPA landscape and assesses 23 technology providers across several key dimensions.

    • Named a Leader in the ISG Provider Lens™ Next-Gen ADM Solutions 2022 – Low-Code/No-Code Development Platforms report. The report recognizes UiPath as an innovation leader at the convergence of enterprise automation and low-code application development, and notes that "UiPath Apps is a top choice for customers looking to rapidly develop automation-powered applications."

Conference Call and Webcast

UiPath will host a conference call today, Thursday, December 1, 2022, at 5:00 p.m. Eastern Time, to discuss the Company's third quarter fiscal 2023 financial results and guidance. To access this call, dial 1-201-689-8057 (domestic) or 1-877-407-8309 (international). The passcode is 13734091. A live webcast of this conference call will be available on the "Investor Relations" page of UiPath’s website (https://ir.uipath.com), and a replay will also be archived on the website for one year.

About UiPath

UiPath has a vision to deliver the Fully Automated Enterprise™, one where companies use automation to unlock their greatest potential. UiPath offers an end-to-end platform for automation, combining the leading Robotic Process Automation (RPA) solution with a full suite of capabilities that enable every organization to rapidly scale digital business operations.

Forward Looking Statements

Statements we make in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, which are usually identified by the use of words such as "anticipates," "believes," "estimates," "expects," "intends," "may," "plans," "projects," "outlook," "seeks," "should," "will," and variations of such words, including the negatives of these words or similar expressions.

We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act and are making this statement for purposes of complying with those safe harbor provisions.

These forward-looking statements include, but are not limited to, statements regarding our guidance for the fourth fiscal quarter and fiscal year end 2023, our strategic plans, objectives and roadmap, the estimated addressable market opportunity for our platform and statements regarding the growth of the automation market. Accordingly, actual results could differ materially, or such uncertainties could cause adverse effects on our results. Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These risks include, but are not limited to, risks and uncertainties related to: the market, political, economic, and business conditions, including geopolitical turmoil and macro-economic effects caused by the war in Ukraine, increasing inflationary cost trends, and foreign exchange volatility; our recent rapid growth, which may not be indicative of our future growth; our limited operating history; our ability to successfully manage our growth; our ability and the ability of our platform to satisfy and adapt to customer demands; our dependency on our existing customers to renew their licenses and purchase additional licenses and products from us and our channel partners; our ability to attract and retain customers; the competitive markets in which we participate; our ability to maintain and expand our distribution channels; our ability to retain and motivate our management and key employees and integrate new team members and manage management transitions; our reliance on third-party providers of cloud-based infrastructure; the potential impact that the COVID-19 pandemic and an economic downturn could have on our or our customers’ businesses, financial condition, and future operating results; our failure to achieve our environmental, social and governance (ESG) goals; and the price volatility of our Class A common stock.

Further information on risks that could cause actual results to differ materially from our guidance can be found in our Annual Report on Form 10-K for the annual period ended January 31, 2022, filed with the SEC on April 4, 2022, in our Quarterly Reports on Form 10-Q filed with the SEC, and in other filings and reports that we may file from time to time with the SEC. Any forward-looking statements contained in this press release are based on assumptions that we believe to be reasonable as of this date. Except as required by law, we assume no obligation to update these forward-looking statements.

Key Performance Metric

Annualized Renewal Run-rate (ARR) is a key performance metric we use in managing our business because it illustrates our ability to acquire new subscription customers and to maintain and expand our relationships with existing subscription customers. We define ARR as annualized invoiced amounts per solution SKU from subscription licenses and maintenance and support obligations assuming no increases or reductions in the subscriptions. ARR does not include the costs we may incur to obtain such subscription licenses or provide such maintenance and does not reflect any actual or anticipated reductions in invoiced value due to contract non-renewals or service cancellations other than for specific bad debt or disputed amounts. Additionally, though we use ARR as a forward-looking metric in the management of our business, it does not include invoiced amounts reported as perpetual licenses or professional services revenue in our consolidated statement of operations, and is not a forecast of future revenue, which can be impacted by contract start and end dates, duration, and renewal rates.

Dollar-based net retention rate represents the rate of net expansion of our ARR from existing customers over the preceding 12 months. We calculate dollar-based net retention rate as of a period end by starting with ARR from the cohort of all customers as of 12 months prior to such period end (Prior Period ARR). We then calculate the ARR from these same customers as of the current period end (Current Period ARR). Current Period ARR includes any expansion and is net of any contraction or attrition over the preceding 12 months but does not include ARR from new customers in the current period. We then divide total Current Period ARR by total Prior Period ARR to arrive at dollar-based net retention rate. Dollar-based net retention rate may fluctuate based on the customers that qualify to be included in the cohort used for calculation and may not reflect our actual performance.

Investors should not place undue reliance on ARR or dollar-based net retention rate as an indicator of future or expected results. Our presentation of these metrics may differ from similarly titled metrics presented by other companies and therefore comparability may be limited.

Non-GAAP Financial Measures

Non-GAAP financial measures are financial measures that are derived from the consolidated financial statements, but that are not presented in accordance with generally accepted accounting principles in the United States (GAAP). This earnings press release includes financial measures defined as non-GAAP financial measures by the SEC, including non-GAAP cost of licenses, non-GAAP cost of subscription services, non-GAAP cost of professional services and other, non-GAAP gross profit and margin, non-GAAP sales and marketing expenses, non-GAAP research and development expenses, non-GAAP general and administrative expenses, non-GAAP operating income (loss) and margin, non-GAAP net income (loss), and non-GAAP net income (loss) per share. These non-GAAP financial measures exclude:

  • stock-based compensation expense;

  • amortization of acquired intangibles;

  • employer payroll tax expense related to employee equity transactions;

  • restructuring costs;

  • charitable donation of Class A common stock; and

  • in the case of non-GAAP net income (loss), tax adjustments associated with the add-back items, as applicable.

Additionally, this earnings release presents non-GAAP adjusted free cash flow, which is calculated by adjusting GAAP operating cash flows for the impact of purchases of property and equipment, capitalization of software development costs, cash paid for employer payroll taxes related to employee equity transactions, net payments/receipts of employee tax withholdings on stock option exercises, and cash paid for restructuring costs.

UiPath uses these non-GAAP financial measures internally in analyzing its financial results, and believes they are useful to investors, by excluding the effects of special items that do not reflect the ordinary earnings of our operations, and as a supplement to GAAP measures. UiPath believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing its financial results with other companies in UiPath’s industry, many of which present similar non-GAAP financial measures to investors. Investors should consider these non-GAAP financial measures in addition to, and not as a substitute for, our financial performance measures prepared in accordance with GAAP. Further, our non-GAAP information may be different from the non-GAAP information provided by other companies. The information below provides a reconciliation of non-GAAP financial measures used in this press release to the most directly comparable GAAP financial measures. We encourage investors to consider our GAAP results alongside our supplemental non-GAAP measures, and to review the reconciliation between GAAP results and non-GAAP measures that is included at the end of this earnings press release. This earnings press release and any future releases containing such non-GAAP reconciliations can also be found on the "Investor Relations" page of UiPath’s website at https://ir.uipath.com.

UiPath, Inc.

Condensed Consolidated Statements of Operations

in thousands, except per share data

(unaudited)

Three Months Ended October 31,

Nine Months Ended October 31,

2022

2021

2022

2021

Revenue:

Licenses

$

118,175

$

111,608

$

338,875

$

307,371

Subscription services

130,159

97,963

370,309

265,924

Professional services and other

14,410

11,245

40,848

29,259

Total revenue

262,744

220,816

750,032

602,554

Cost of revenue:

Licenses

3,208

2,626

7,915

7,514

Subscription services

20,578

15,659

63,949

42,076

Professional services and other

18,982

24,815

60,496

78,114

Total cost of revenue

42,768

43,100

132,360

127,704

Gross profit

219,976

177,716

617,672

474,850

Operating expenses:

Sales and marketing

156,469

172,906

527,798

522,925

Research and development

67,341

61,559

203,880

212,245

General and administrative

63,157

59,498

189,130

189,747

Total operating expenses

286,967

293,963

920,808

924,917

Operating loss

(66,991

)

(116,247

)

(303,136

)

(450,067

)

Interest income

9,561

899

15,057

2,606

Other income (expense), net

888

(4,300

)

(2,523

)

(8,743

)

Loss before income taxes

(56,542

)

(119,648

)

(290,602

)

(456,204

)

Provision for income taxes

1,182

3,139

10,061

6,272

Net loss

$

(57,724

)

$

(122,787

)

$

(300,663

)

$

(462,476

)

Net loss per share attributable to common stockholders, basic and diluted

$

(0.10

)

$

(0.23

)

$

(0.55

)

$

(1.08

)

Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted

550,164

531,718

546,087

426,811

UiPath, Inc.

Condensed Consolidated Balance Sheets

in thousands

(unaudited)

As of

October 31,
2022

January 31,
2022

Assets

Current assets

Cash and cash equivalents

$

1,451,152

$

1,768,723

Marketable securities

225,605

96,417

Accounts receivable, net of allowance for doubtful accounts of $3,279 and $2,566, respectively

275,935

251,988

Contract assets

91,551

74,831

Deferred contract acquisition costs

40,168

29,926

Prepaid expenses and other current assets

74,834

55,416

Total current assets

2,159,245

2,277,301

Marketable securities, non-current

2,920

19,523

Contract assets, non-current

9,498

2,730

Deferred contract acquisition costs, non-current

113,568

100,224

Property and equipment, net

28,152

17,176

Operating lease right-of-use assets

50,555

48,953

Intangible assets, net

23,993

16,817

Goodwill

83,844

53,564

Deferred tax asset

7,657

10,628

Other assets, non-current

32,252

25,534

Total assets

$

2,511,684

$

2,572,450

Liabilities and stockholders' equity

Current liabilities

Accounts payable

$

11,253

$

11,515

Accrued expenses and other current liabilities

78,892

87,958

Accrued compensation and employee benefits

98,086

130,673

Deferred revenue

288,412

297,355

Total current liabilities

476,643

527,501

Deferred revenue, non-current

107,633

68,665

Operating lease liabilities, non-current

55,085

49,843

Other liabilities, non-current

12,499

4,524

Total liabilities

651,860

650,533

Commitments and contingencies

Stockholders' equity

Class A common stock

5

4

Class B common stock

1

1

Additional paid-in capital

3,649,474

3,406,959

Accumulated other comprehensive income

6,953

10,899

Accumulated deficit

(1,796,609

)

(1,495,946

)

Total stockholders’ equity

1,859,824

1,921,917

Total liabilities and stockholders’ equity

$

2,511,684

$

2,572,450

UiPath, Inc.

Condensed Consolidated Statements of Cash Flows

in thousands (unaudited)

Nine Months Ended October 31,

2022

2021

Cash flows from operating activities

Net loss

$

(300,663

)

$

(462,476

)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization

12,993

10,697

Amortization of deferred contract acquisition costs

37,967

19,904

Net amortization of premium on marketable securities

501

1,391

Stock-based compensation expense

270,797

438,551

Charitable donation of Class A common stock

5,499

Amortization of operating lease right-of-use assets

8,555

6,013

Provision for deferred income taxes

1,171

(357

)

Abandonment and impairment charges

2,881

Other non-cash (credits) charges, net1

(1,714

)

1,599

Changes in operating assets and liabilities:

Accounts receivable

(33,449

)

(27,028

)

Contract assets

(27,735

)

(29,994

)

Deferred contract acquisition costs

(69,657

)

(80,720

)

Prepaid expenses and other assets

(27,361

)

(2,295

)

Accounts payable

2,414

17,549

Accrued expense and other liabilities

(13,785

)

17,756

Accrued compensation and employee benefits

(26,096

)

(822

)

Operating lease liabilities, net

(488

)

(5,261

)

Deferred revenue

54,232

46,544

Net cash used in operating activities

(103,938

)

(48,949

)

Cash flows from investing activities

Purchases of marketable securities

(204,311

)

(161,214

)

Sales of marketable securities

89,383

Maturities of marketable securities

93,298

58,109

Purchases of property and equipment

(21,614

)

(5,719

)

Capitalization of software development costs

(2,950

)

Payments related to business acquisitions, net of cash acquired

(29,542

)

(5,498

)

Other investing, net

(507

)

(1,231

)

Net cash used in investing activities

(162,676

)

(29,120

)

Cash flows from financing activities

Proceeds from exercise of stock options

7,605

9,687

Payments of tax withholdings on net settlement of equity awards

(53,300

)

(10,300

)

Net (payments) receipts of tax withholdings on sell-to-cover equity award transactions

(10,132

)

20,418

Proceeds from employee stock purchase plan contributions

13,525

13,766

Repurchase of unvested early exercised stock options

(1,493

)

Proceeds from initial public offering, net of underwriting discounts and commissions

692,369

Payments of initial public offering costs

(3,734

)

Proceeds from issuance of convertible preferred stock

750,000

Payments of issuance costs for convertible preferred stock

(164

)

Net cash (used in) provided by financing activities

(43,795

)

1,472,042

Effect of exchange rate changes

(7,162

)

11,254

Net (decrease) increase in cash, cash equivalents, and restricted cash

(317,571

)

1,405,227

Cash, cash equivalents, and restricted cash - beginning of period

1,768,723

371,190

Cash, cash equivalents, and restricted cash - end of period

$

1,451,152

$

1,776,417

1 Prior period amounts have been combined to conform to current period presentation

UiPath, Inc.

Reconciliation of GAAP Cost of Revenue and Gross Profit to Non-GAAP Cost of Revenue and Gross Profit

in thousands, except percentages

(unaudited)

Three Months Ended October 31,

Nine Months Ended October 31,

2022

2021

2022

2021

Licenses

GAAP cost of licenses

$

3,208

$

2,626

$

7,915

$

7,514

Less: Amortization of acquired intangible assets

777

628

1,935

1,910

Non-GAAP cost of licenses

$

2,431